NF-κB repression by PIAS3 mediated ReLA SUMOylation

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Liu, Yuangang ^a   Bridges, Rebecca ^a   Wortham, Aaron ^a   Kulesz Martin, Molly ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEPTOMYCIN B; MUTANT PROTEIN; PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN INHIBITOR OF ACTIVATED STAT 3; SUMO PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; GUANOSINE 3',5' POLYPHOSPHATE SYNTHETASES; GUANOSINE 3',5'-POLYPHOSPHATE SYNTHETASES; LIGASE; LUCIFERASE; UNSATURATED FATTY ACID;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; DNA BINDING; FIBROBLAST; HUMAN; HUMAN CELL; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; NULL CELL; PROTEIN ACTIVATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEIN REPRESSION; PROTEIN SUBUNIT; PROTEIN TRANSPORT; REGULATORY MECHANISM; SUMOYLATION; WILD TYPE; ACTIVE TRANSPORT; CELL STRAIN HEK293; DRUG ANTAGONISM; DRUG EFFECT; FEEDBACK SYSTEM; GENETICS; IMMUNOBLOTTING; LENTIVIRINAE; METABOLISM; MOLECULAR CLONING; PHYSIOLOGY; PLASMID;

ACTIVE TRANSPORT, CELL NUCLEUS; CLONING, MOLECULAR; FATTY ACIDS, UNSATURATED; FEEDBACK, PHYSIOLOGICAL; FIBROBLASTS; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; LENTIVIRUS; LIGASES; LUCIFERASES; NF-KAPPA B; PLASMIDS; PROTEIN INHIBITORS OF ACTIVATED STAT; SUMOYLATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861386847     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037636     Document Type: Article

References (38)

1. Ghosh S, Karin M, (2002) Missing pieces in the NF-kappaB puzzle. Cell 109 Supplpp. S81-96.
2. Hoffmann A, Baltimore D, (2006) Circuitry of nuclear factor kappaB signaling. Immunol Rev 210: 171-186.
3. Arenzana-Seisdedos F, Thompson J, Rodriguez MS, Bachelerie F, Thomas D, et al. (1995) Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B. Mol Cell Biol 15: 2689-2696.
4. Arenzana-Seisdedos F, Turpin P, Rodriguez M, Thomas D, Hay RT, et al. (1997) Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. J Cell Sci 110 (Pt 3): 369-378.
5. Hoffmann A, Levchenko A, Scott ML, Baltimore D, (2002) The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298: 1241-1245.
6. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, et al. (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430: 694-699.
7. Brummelkamp TR, Nijman SM, Dirac AM, Bernards R, (2003) Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424: 797-801.
8. Kovalenko A, Chable-Bessia C, Cantarella G, Israel A, Wallach D, et al. (2003) The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 424: 801-805.
9. Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, et al. (2003) CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424: 793-796.
10. Girdwood DW, Tatham MH, Hay RT, (2004) SUMO and transcriptional regulation. Semin Cell Dev Biol 15: 201-210.
11. Desterro JM, Rodriguez MS, Hay RT, (1998) SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 2: 233-239.
12. Mabb AM, Wuerzberger-Davis SM, Miyamoto S, (2006) PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress. Nat Cell Biol 8: 986-993.
13. Shuai K, Liu B, (2005) Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat Rev Immunol 5: 593-605.
14. Liu B, Yang R, Wong KA, Getman C, Stein N, et al. (2005) Negative regulation of NF-kappaB signaling by PIAS1. Mol Cell Biol 25: 1113-1123.
15. Jang HD, Yoon K, Shin YJ, Kim J, Lee SY, (2004) PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit. J Biol Chem 279: 24873-24880.
16. Liu Y, Lagowski JP, Gao S, Raymond JH, White CR, et al. (2010) Regulation of the psoriatic chemokine CCL20 by E3 ligases Trim32 and Piasy in keratinocytes. J Invest Dermatol 130: 1384-1390.
17. Garcia-Dominguez M, Reyes JC, (2009) SUMO association with repressor complexes, emerging routes for transcriptional control. Biochim Biophys Acta 1789: 451-459.
18. Dorval V, Fraser PE, (2006) Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein. J Biol Chem 281: 9919-9924.
19. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, et al. (1997) IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278: 860-866.
20. Schneider BL, Bowden GT, Sutter C, Schweizer J, Han KA, et al. (1993) 7,12-Dimethylbenz[a]anthracene-induced mouse keratinocyte malignant transformation independent of Harvey ras activation. JInvest Dermatol 101: 595.
21. Liu Y, Lagowski J, Sundholm A, Sundberg A, Kulesz-Martin M, (2007) Microtubule disruption and tumor suppression by mitogen-activated protein kinase phosphatase 4. Cancer Res 67: 10711-10719.
22. Liu Y, Asch H, Kulesz-Martin MF, (2001) Functional quantification of DNA-binding proteins p53 and estrogen receptor in cells and tumor tissues by DNA affinity immunoblotting. Cancer Res 61: 5402.
23. Rodriguez MS, Dargemont C, Hay RT, (2001) SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J Biol Chem 276: 12654-12659.
24. Hay RT, (2005) SUMO: a history of modification. Mol Cell 18: 1-12.
25. Wissink S, van Heerde EC, Schmitz ML, Kalkhoven E, van der Burg B, et al. (1997) Distinct domains of the RelA NF-kappaB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor. J Biol Chem 272: 22278-22284.
26. Wang J, Scully K, Zhu X, Cai L, Zhang J, et al. (2007) Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 446: 882-887.
27. Iniguez-Lluhi JA, Pearce D, (2000) A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy. Mol Cell Biol 20: 6040-6050.
28. Matic I, Schimmel J, Hendriks IA, van Santen MA, van de Rijke F, et al. (2010) Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif. Mol Cell 39: 641-652.
29. Shin JA, Choi ES, Kim HS, Ho JC, Watts FZ, et al. (2005) SUMO modification is involved in the maintenance of heterochromatin stability in fission yeast. Mol Cell 19: 817-828.
30. Hari KL, Cook KR, Karpen GH, (2001) The Drosophila Su(var)2-10 locus regulates chromosome structure and function and encodes a member of the PIAS protein family. Genes Dev 15: 1334-1348.
31. David G, Neptune MA, DePinho RA, (2002) SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities. J Biol Chem 277: 23658-23663.
32. Lin X, Sun B, Liang M, Liang YY, Gast A, et al. (2003) Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding. Mol Cell 11: 1389-1396.
33. Ouyang J, Shi Y, Valin A, Xuan Y, Gill G, (2009) Direct binding of CoREST1 to SUMO-2/3 contributes to gene-specific repression by the LSD1/CoREST1/HDAC complex. Mol Cell 34: 145-154.
34. Liu B, Tahk S, Yee KM, Fan G, Shuai K, (2010) The ligase PIAS1 restricts natural regulatory T cell differentiation by epigenetic repression. Science 330: 521-525.
35. Li Y, Reddy MA, Miao F, Shanmugam N, Yee JK, et al. (2008) Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation. J Biol Chem 283: 26771-26781.
36. Kiernan R, Bres V, Ng RW, Coudart MP, El Messaoudi S, et al. (2003) Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J Biol Chem 278: 2758-2766.
37. Werner SL, Kearns JD, Zadorozhnaya V, Lynch C, O'Dea E, et al. (2008) Encoding NF-kappaB temporal control in response to TNF: distinct roles for the negative regulators IkappaBalpha and A20. Genes Dev 22: 2093-2101.
38. Zabel U, Baeuerle PA, (1990) Purified human I kappa B can rapidly dissociate the complex of the NF-kappa B transcription factor with its cognate DNA. Cell 61: 255-265.